Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lampertico

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 27, 2022
Preprocedural prophylaxis with blood products in patients with cirrhosis: Results from a survey of the Italian Association for the Study of the Liver (AISF)G Tosetti, E Farina, R Caccia, et al.
Alimentary Pharmacology & Therapeutics|June 20, 2018
Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long-term analogue therapy for hepatitis BA Loglio, M Iavarone, G Grossi, et al.
Hepatology (Baltimore, Md.)|December 16, 1997
A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serumP Lampertico, E Del Ninno, A Manzin, et al.
Journal of Viral Hepatitis|January 25, 2007
Increased expression of vascular endothelial growth factor in small hepatocellular carcinomaM Iavarone, P Lampertico, F Iannuzzi, et al.
Bone Marrow Transplantation|April 13, 2010
Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCTM Viganò, C Vener, P Lampertico, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 1, 1991
Detection of hepatitis C virus sequences in liver tissue by the polymerase chain reactionY S Shieh, K S Shim, P Lampertico, et al.
Alimentary Pharmacology & Therapeutics|June 30, 2018
A baseline tool for predicting response to peginterferon alfa-2a in HBeAg-positive patients with chronic hepatitis BH L Y Chan, D Messinger, G V Papatheodoridis, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 7, 2008
The use of molecular assays in the management of viral hepatitisA Mangia, F Antonucci, M Brunetto, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 27, 2007
Prophylaxis and treatment of hepatitis B in immunocompromised patientsA Marzano, E Angelucci, P Andreone, et al.
Alimentary Pharmacology & Therapeutics|July 3, 2018
A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis BR El Sharkawy, K Thabet, P Lampertico, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 27, 2022
Preprocedural prophylaxis with blood products in patients with cirrhosis: Results from a survey of the Italian Association for the Study of the Liver (AISF)G Tosetti, E Farina, R Caccia, et al.
Alimentary Pharmacology & Therapeutics|June 20, 2018
Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long-term analogue therapy for hepatitis BA Loglio, M Iavarone, G Grossi, et al.
Hepatology (Baltimore, Md.)|December 16, 1997
A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serumP Lampertico, E Del Ninno, A Manzin, et al.
Journal of Viral Hepatitis|January 25, 2007
Increased expression of vascular endothelial growth factor in small hepatocellular carcinomaM Iavarone, P Lampertico, F Iannuzzi, et al.
Bone Marrow Transplantation|April 13, 2010
Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCTM Viganò, C Vener, P Lampertico, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 1, 1991
Detection of hepatitis C virus sequences in liver tissue by the polymerase chain reactionY S Shieh, K S Shim, P Lampertico, et al.
Alimentary Pharmacology & Therapeutics|June 30, 2018
A baseline tool for predicting response to peginterferon alfa-2a in HBeAg-positive patients with chronic hepatitis BH L Y Chan, D Messinger, G V Papatheodoridis, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 7, 2008
The use of molecular assays in the management of viral hepatitisA Mangia, F Antonucci, M Brunetto, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 27, 2007
Prophylaxis and treatment of hepatitis B in immunocompromised patientsA Marzano, E Angelucci, P Andreone, et al.
Alimentary Pharmacology & Therapeutics|July 3, 2018
A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis BR El Sharkawy, K Thabet, P Lampertico, et al.
Pageof 6